VNN3 is a potential novel biomarker for predicting prognosis in clear cell renal cell carcinoma
Although pathological observations provide approximate prognoses, it is difficult to achieve prognosis in patients with existing prognostic factors. Therefore, it is very important to find appropriate biomarkers to achieve accurate cancer prognosis. Renal cell carcinoma (RCC) has several subtypes, t...
Main Authors: | Mihyang Ha, Hoim Jeong, Jong Seong Roh, Beomgu Lee, Dongjun Lee, Myoung-Eun Han, Sae-Ock Oh, Dong Hyun Sohn, Yun Hak Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-03-01
|
Series: | Animal Cells and Systems |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19768354.2019.1583126 |
Similar Items
-
Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis
by: Mihyang Ha, et al.
Published: (2019-04-01) -
Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma
by: Mihyang Ha, et al.
Published: (2019-09-01) -
Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma
by: Hanxiang Liu, et al.
Published: (2021-09-01) -
Construction and validation of a seven-gene signature for predicting overall survival in patients with kidney renal clear cell carcinoma via an integrated bioinformatics analysis
by: Huiming Jiang, et al.
Published: (2020-05-01) -
Identification of a Novel Signature and Construction of a Nomogram Predicting Overall Survival in Clear Cell Renal Cell Carcinoma
by: Xiangkun Wu, et al.
Published: (2020-09-01)